BioSpace News Archive

Codagenix Inc. today announced the presentation of preclinical data for CodaLytic™, a codon-modified virus being developed for breast cancer immunovirotherapy, at the Society for the Immunotherapy of Cancer (SITC) 38th Annual Meeting being held virtually and in-person November 1-5, 2023 in San Diego, California.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended September 30, 2023, and updated full-year guidance.

Clarix Imaging®, a pioneering force in surgical oncology, proudly announces a collaboration with Mayo Clinic to catalyze new surgical advancements using Clarix Imaging’s proprietary and patented volumetric specimen imaging hardware and software technology.

Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the third quarter ended September 30, 2023.

Bausch + Lomb Corporation today announced three podium presentations and seven poster presentations during the American Academy of Ophthalmology (AAO) annual meeting, which will take place in San Francisco Nov. 3-6, 2023.

Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended September 30, 2023.

SIGA Technologies, Inc. today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, November 7th, 2023.

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, today announced two upcoming events in November.

Altimmune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its clinical program investigating pemvidutide for the treatment of NASH.

CorVel Corporation (NASDQ:CRVL), a national provider of risk management solutions, today announced the promotion of Jeff Gurtcheff to Chief Claims Officer.